{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:09:42Z","timestamp":1760188182464},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4572,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1046\/j.1523-1755.2003.00029.x","type":"journal-article","created":{"date-parts":[[2003,5,14]],"date-time":"2003-05-14T12:57:35Z","timestamp":1052917055000},"page":"2020-2027","source":"Crossref","is-referenced-by-count":44,"title":["Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia"],"prefix":"10.1016","volume":"63","author":[{"given":"Eduardo","family":"Slatopolsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Finch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriana","family":"Dusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Staniforth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo","family":"Wein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: A disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"issue":"Suppl 73","key":"10.1046\/j.1523-1755.2003.00029.x_bb0015","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"56","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0020","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-199707000-00004","article-title":"Regulation of parathyroid cell proliferation","volume":"6","author":"Silver","year":"1997","journal-title":"Curr Op Nephrol Hyperten"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0030","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure in rats: The effects of calcium, phosphate and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0272-6386(96)90473-4","article-title":"Phosphorus accelerated the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure","volume":"28","author":"Denda","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0045","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1681\/ASN.V12112511","article-title":"Role of calcium x phosphate product and bone associated proteins on vascular calcification in renal failure","volume":"12","author":"Cozzolino","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0050","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0055","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analog of 1,25-(OH)2D3, 19-nor-1,25-(OH)2D2, suppresses PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0065","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-\u03b1-25-dihydroxyvitamin D2 (paracalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0075","first-page":"199","article-title":"Vitamin D control of osteoblast function and bone extracellular matrix mineralization","volume":"11","author":"van Leeuwen","year":"2001","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0080","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0085","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1681\/ASN.V1271468","article-title":"Relative potencies of 1,25-(OH)2D3 and 19-Nor-1,25-(OH)2D2 on inducing differentiation and markers of bone formation in MG-63 cells","volume":"12","author":"Finch","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0090","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI111096","article-title":"Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: Implications for the microanatomic and cellular mechanisms of bone loss","volume":"72","author":"Parfitt","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0095","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Min Res"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0100","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/ajkd.2001.29283","article-title":"Strategies to minimize bone disease in renal failure","volume":"38","author":"Martin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1010002710485","article-title":"Vitamin D nutrition and bone disease in adults","volume":"2","author":"Mawer","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0110","doi-asserted-by":"crossref","first-page":"73s","DOI":"10.1111\/j.1365-2265.1977.tb03365.x","article-title":"Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3","volume":"7","author":"Peacock","year":"1977","journal-title":"Clin Endocrinol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0115","doi-asserted-by":"crossref","first-page":"39s","DOI":"10.1111\/j.1365-2265.1977.tb03360.x","article-title":"Bone histomorphometry in patients with chronic renal failure: Effect of 1 alpha-hydroxyvitamin D3","volume":"7","author":"Melsen","year":"1977","journal-title":"Clin Endocrinol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/snep.2001.24938","article-title":"Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease","volume":"21","author":"Sanchez","year":"2001","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0125","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","article-title":"A structural approach to renal bone disease","volume":"13","author":"Parfitt","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF00868726","article-title":"Alphacalcidol oral pulses normalize uremic hyperparathyroidism prior to dialysis","volume":"9","author":"Ala-Houhala","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0140","first-page":"362","article-title":"24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure","volume":"53","author":"Gal-Moscovici","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jbmr.5650100205","article-title":"Effects of 24R,25-dihydroxyvitamin D3 in combination with 1\u03b1-hydroxyvitamin D3 in predialysis renal insufficiency: Biochemistry and histomorphometry of cancellous bone","volume":"10","author":"Birkenhager-Frenkel","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1523-1755.1999.055003821.x","article-title":"22-oxacalcitriol suppress secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure","volume":"55","author":"Monier-Faugere","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0155","series-title":"Atlas of Mineralized Bone Histology","author":"MALLUCHE","year":"1986"},{"issue":"Suppl 29","key":"10.1046\/j.1523-1755.2003.00029.x_bb0160","first-page":"S48","article-title":"The effects of 1,25-(OH)2D3 administration on bone in patients with renal failure","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25-(OH)2D3: Administration in moderate renal failure: A prospective double-blind trial","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0170","first-page":"48","article-title":"Management of renal osteodystrophy with 1,25-(OH)2D3. II. Effects on histopathology of bone: Evidence for healing of osteomalacia","volume":"2","author":"Malluche","year":"1979","journal-title":"Miner Electrolyte Metab"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0175","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteotis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0180","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/ajkd.2000.17667","article-title":"Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro","volume":"36","author":"Balint","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00029.x_bb0185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Calcium kinetics in patients with renal osteodystrophy: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815491197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815491197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T02:28:11Z","timestamp":1623032891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815491197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0085253815491197"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00029.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}